Search

Your search keyword '"F. Rozenberg"' showing total 267 results

Search Constraints

Start Over You searched for: Author "F. Rozenberg" Remove constraint Author: "F. Rozenberg"
267 results on '"F. Rozenberg"'

Search Results

51. Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.

52. Human TMEFF1 is a restriction factor for herpes simplex virus in the brain.

53. Correction: COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants.

54. Maternal and neonatal outcomes of French prospective multicenter cohort study COVIPREG during the first two COVID-19 waves.

55. COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants.

56. The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants.

57. Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.

58. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

59. Encephalitis and poor neuronal death-mediated control of herpes simplex virus in human inherited RIPK3 deficiency.

60. Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers.

62. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.

63. Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria.

64. Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis.

65. Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.

66. Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients.

67. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.

68. Clinical and Virological Characteristics and Prognostic Factors in Viral Necrotizing Retinitis.

69. Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.

70. Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency.

71. JC Polyomavirus Whole Genome Sequencing at the Single-Molecule Level Reveals Emerging Neurotropic Populations in Progressive Multifocal Leukoencephalopathy.

72. Neuroinflammatory Disease following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children.

74. Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patients.

76. Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases.

77. Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses.

78. CGRP inhibits human Langerhans cells infection with HSV by differentially modulating specific HSV-1 and HSV-2 entry mechanisms.

79. Neurological complications of varicella zoster virus reactivation: Prognosis, diagnosis, and treatment of 72 patients with positive PCR in the cerebrospinal fluid.

80. Lack of Effect of Gluten Challenge on Fecal Microbiome in Patients With Celiac Disease and Non-Celiac Gluten Sensitivity.

81. Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis.

82. Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child.

83. Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.

84. Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients.

85. Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child.

86. Differential levels of IFNα subtypes in autoimmunity and viral infection.

87. Genetic, Immunological, and Clinical Features of 32 Patients with Autosomal Recessive STAT1 Deficiency.

88. Inherited deficiency of stress granule ZNFX1 in patients with monocytosis and mycobacterial disease.

89. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.

90. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.

91. Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening method.

92. Transmission Routes of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers of a French University Hospital in Paris, France.

93. Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient.

94. Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.

95. Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency.

96. Clinical Features and Diagnosis of Anterior Segment Inflammation Related to Cytomegalovirus in Immunocompetent African, Asian, and Caucasian Patients.

97. Human T-bet Governs Innate and Innate-like Adaptive IFN-γ Immunity against Mycobacteria.

99. Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study.

100. [Herpes simplex virus and central nervous system infections: encephalitis, meningitis, myelitis].

Catalog

Books, media, physical & digital resources